← Leaderboards
Can Cenik
Stanford University
$2,339,896
Attributed
$2,557,833
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $627K · FY2016–25$1M$750K$500K$250K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,557,833 · 4
By mechanism
R35$1,167,690 · 1
R00$746,996 · 1
R21$435,875 · 1
K99$207,272 · 1
Top collaborators
- Steven Alexander Vokes2 shared
Most similar at Stanford University
Same institution · by research overlap
- Marco Conti$20,166,893
- Shawn L. Chavez$3,687,075
- Xiaoyan Zheng$4,245,429
- Philip A Beachy$22,123,478
- Douglas P Mortlock$3,035,954
Others in their field
Top investigators on “Proteins”
- David Heimbrook · Leidos Biomedical Research, Inc.$354,061,551
- Randall J Bateman · Washington University$187,292,085
- Paul S. Aisen · Cognition Therapeutics, Inc.$175,382,342
- Reisa A. Sperling · Banner Health$145,046,481
- Barton F Haynes · Duke University$136,029,850
- Joseph L Goldstein · University Of Texas Sw Med Ctr/Dallas$102,433,280
Research focus
ProteinsGene ExpressionTechnologyMessenger RnaMeasurementCellsGenetic TranscriptionTranslationsAllelesProgramsVariantSamplingMalignant NeoplasmsCell ProliferationCell LineCancer BiologyCatalogsDna Sequence AlterationEmbryoEventBaseCrispr/Cas TechnologyDimensionsCancer Patient
Grant awards (10)
Single cell quantification of translation control in early mouse development$389,230
R35 · FY2025 · GM · contact PI
Single cell quantification of translation control in early mouse development$389,230
R35 · FY2024 · GM · contact PI
Single cell quantification of translation control in early mouse development$389,230
R35 · FY2023 · GM · contact PI
Translational regulation of limb bud initiation$237,750
R21 · FY2023 · HD
Translational regulation of limb bud initiation$198,125
R21 · FY2022 · HD
Characterization of recurrent cancer mutations that cause misregulated translation$248,999
R00 · FY2020 · CA · contact PI
Characterization of recurrent cancer mutations that cause misregulated translation$248,998
R00 · FY2019 · CA · contact PI
Characterization of recurrent cancer mutations that cause misregulated translation$248,999
R00 · FY2018 · CA · contact PI
Characterization of recurrent cancer mutations that cause misregulated translation$103,636
K99 · FY2017 · CA · contact PI
Characterization of recurrent cancer mutations that cause misregulated translation$103,636
K99 · FY2016 · CA · contact PI